The CEO of Novo Nordisk, Lars Fruergaard Jørgensen, will testify before the Senate Health, Education, Labor and Pensions Committee on Tuesday regarding the high prices of the company's weight loss drug Wegovy and diabetes treatment Ozempic. Sen. Bernie Sanders, who chairs the committee, alleges that Novo Nordisk charges significantly higher prices for its drugs in the US compared to other countries.
Novo Nordisk 's top executive is slated to face a Senate grilling over the high prices of the company's weight loss drug Wegovy and diabetes treatment Ozempic .
Sen. Bernie Sanders, who chairs the Senate panel, argues that Novo Nordisk charges Americans substantially higher prices for its blockbuster injections than it does for patients in other countries.hearing Sanders contends that Novo Nordisk charges Americans substantially higher prices for its blockbuster drugs than it does for patients in other countries. Before insurance, Ozempic costs nearly
Feeling out of the loop? We'll catch you up on the Chicago news you need to know. Sign up for the weekly
Novo Nordisk Ozempic Wegovy Drug Prices Senate Hearing
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug pricesSen. Bernie Sanders argues that Novo Nordisk charges Americans substantially higher prices for its drugs than it does for patients in other countries.
Read more »
Novo Nordisk’s New Obesity Pill Beats Wegovy In Early TrialRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »
Novo Nordisk weight-loss drug is effective for kids as young as 6, study showsA drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study…
Read more »
Ozempic, Wegovy maker Novo Nordisk faces hearing over high cost of weight loss drugsBlockbuster drugs Ozempic and Wegovy have sparked conversation and changed weight loss worldwide. In an exclusive interview, NBC News’ Megan Fitzgerald sits down with Novo Nordisk CEO Lars Fruergaard Jørgensen who helmed it all, and presses him on the high price, drug shortages, and long-term effects.
Read more »
Novo Nordisk weight-loss drug is effective for kids as young as 6, study showsA drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study…
Read more »
Ahead of Novo Nordisk Hearing, 250 Clinicians Demand Affordable Access to Ozempic and WegovyNewswire Editor is a Common Dreams staff position.
Read more »